CG-806 |
CG-806; CG-026806 |
Phase 2 Clinical |
Crystalgenomics Inc, Aptose |
Hematologic Neoplasms; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
FN-1501 |
FN-1501 |
Phase 1 Clinical |
China Pharmaceutical University |
Neoplasms; Leukemia, Myeloid, Acute |
Details
|
QBH-196 |
QBH-196 |
Phase 1 Clinical |
Shenyang Pharmaceutical University |
Stomach Neoplasms |
Details
|
SKI-G-801 |
G-801; SKI-G-801; G-749 Hydrochloride |
Phase 1 Clinical |
Oscotec |
Leukemia, Myeloid, Acute |
Details
|
FF-10101 |
FF-10101; FF-10101-01; FF-10101 succinate |
Phase 2 Clinical |
Fujifilm Corp |
Leukemia, Myeloid, Acute |
Details
|
Mivavotinib |
TAK-659 |
Phase 2 Clinical |
Takeda Pharmaceutical Co Ltd |
Solid tumours; Squamous Cell Carcinoma of Head and Neck; Lymphoma, Large B-Cell, Diffuse; Triple Negative Breast Neoplasms; Lymphoma, Follicular; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma |
Details
|
Ningetinib Tosylate |
CT-053; CT-053-PTSA |
Phase 2 Clinical |
Hec Pharm Co Ltd |
Intestinal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Leukemia, Myeloid, Acute; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular |
Details
|
Clifutinib Besylate |
|
Phase 1 Clinical |
Guangdong Dongyangguang Pharmaceutical Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Flysyn |
4G8-SDIEM |
Phase 2 Clinical |
Synimmune |
Leukemia, Myeloid, Acute |
Details
|
Lestaurtinib |
SP-924; CEP-701; KT-5555; SPM-924; A-154475.0 |
Phase 3 Clinical |
Kyowa Hakko Kirin |
Bone Marrow Neoplasms; Leukemia, Myeloid; Polycythemia Vera; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms; Psoriasis; Leukemia, Myeloid, Acute; Thrombocythemia, Essential |
Details
|
XY0206 |
XY-0206 |
Phase 1 Clinical |
Shijiazhuang Yiling Pharmaceutical Co Ltd, Nanjing University Of Chinese Medicine |
Solid tumours; Leukemia, Myeloid, Acute |
Details
|
Fms-like tyrosine kinase 3 ligand (Celldex Therapeutics) |
CDX-301 |
Phase 2 Clinical |
Amgen Inc |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hodgkin Disease; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
E-6201 |
E-6201 |
Phase 2 Clinical |
Eisai Co Ltd |
Leukemia, Myelomonocytic, Chronic; Myeloproliferative Disorders; Myelodysplastic Syndromes; Psoriasis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Brain metastases; Melanoma |
Details
|
SEL-24 |
SEL-24; MEN-1703; SEL-24-1; SEL-24-B489; SEL-24 program |
Phase 2 Clinical |
Selvita |
Leukemia, Myeloid, Acute |
Details
|
MAX-40279 |
Max-40279; MAX-40279-01; MAX-4; MAX-40279-001 |
Phase 1 Clinical |
Guangzhou Maxinovel Pharmaceiticals Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
RIVAL-01 |
TBio-6517 |
Phase 2 Clinical |
Turnstone Biologics |
Triple Negative Breast Neoplasms; Colorectal Neoplasms |
Details
|
Sorafenib/MG-005 |
MGD-1509 |
Phase 2 Clinical |
Metagone Biotech, Tri-Service General Hospital |
Neoplasms |
Details
|
Hydroxychloroquine/Sorafenib |
|
Phase 1 Clinical |
Vg Life Sciences |
Ovarian Neoplasms |
Details
|
NMS-03592088 |
NMS-P088; NMS-03592088 |
Phase 2 Clinical |
Nerviano Medical Sciences |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute |
Details
|
MRX-2843 |
MRX-2843; UNC-2025; UNC-2371 |
Phase 1 Clinical |
Meryx, University Of North Carolina At Chapel Hill, University Of Colorado At Denver |
Solid tumours; Pathologic Processes; Neoplastic Processes; Neoplasm Metastasis |
Details
|
PLX-7486 |
PLX-7486; PLX7486-TsOH |
Phase 1 Clinical |
Daiichi Sankyo Co Ltd |
Giant Cell Tumor of Tendon Sheath; Solid tumours; Pancreatic Neoplasms |
Details
|
HM-43239 |
|
Phase 2 Clinical |
Hanmi Pharmaceutical Co Ltd |
Leukemia, Myeloid, Acute |
Details
|
Dovitinib |
TKI-258; CHIR-258; GFKI-258; CHIR-258LC; NVP-TKI258 |
Phase 2 Clinical |
Novartis Pharma Ag |
Carcinoma, Adenoid Cystic; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular; Thyroid Neoplasms; Leukemia, Myeloid, Acute; Endometrial Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Hepatic Insufficiency; Prostatic Neoplasms; Breast Neoplasms; Solid tumours; Adrenocortical Carcinoma; Multiple Myeloma; Pancreatic Neoplasms; Glioblastoma; Adenocarcinoma, Scirrhous; Carcinoma; Carcinoma, Renal Cell; Stomach Neoplasms; Liver Neoplasms; Linitis Plastica; Stomach Diseases |
Details
|
SKLB-1028 |
SKLB-1028 |
Phase 3 Clinical |
Sichuan University, CSPC Pharmaceutical Group Ltd |
Leukemia, Myeloid, Acute |
Details
|
CA-4948 |
AU-4948; CA-4948 |
Phase 1 Clinical |
Aurigene |
Hematologic Neoplasms; Leukemia, Myeloid; Myelodysplastic Syndromes; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute |
Details
|
Crenolanib Besylate |
ARO-002; CP-868596; ARO-002-26; IND-112201; CP-868596-26 |
Phase 3 Clinical |
Pfizer Pharmaceuticals Ltd (China) |
Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Glioblastoma; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute; Glioma; Carcinoma, Non-Small-Cell Lung |
Details
|
AMG-427 (Amgen) |
AMG-427 |
|
Amgen Inc |
|
Details
|
AMG-553 |
AMG-553 |
Phase 1 Clinical |
Amgen Inc |
Leukemia, Myeloid, Acute |
Details
|
Pacritinib |
SB-1518; ONX-0803 |
Phase 3 Clinical |
Syncore Biotechnology Co Ltd, Concert |
Lymphoma, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Polycythemia Vera; Hodgkin Disease; Myelodysplastic Syndromes; Myeloproliferative Disorders; Leukemia, Myelomonocytic, Chronic; Coronavirus Disease 2019 (COVID-19); Lymphoma, Mantle-Cell; Coronavirus Infections; Primary Myelofibrosis; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Lymphoma; Thrombocythemia, Essential |
Details
|
Zotiraciclib |
SB-1317; TG-02 |
Phase 1 Clinical |
Syncore Biotechnology Co Ltd |
Myeloproliferative Disorders; Blast Crisis; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Glioma; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Hepatocellular |
Details
|
HYML-122 |
HYML-122; CHMFL-FLT3-122 |
Phase 1 Clinical |
Hefei Academy Of Physical Sciences, Chinese Academy Of Sciences, Hefei Heyuan Pharmaceutical Co Ltd |
Leukemia, Myeloid, Acute |
Details
|